Viewing Study NCT06810895


Ignite Creation Date: 2025-12-24 @ 1:36 PM
Ignite Modification Date: 2026-01-04 @ 4:39 PM
Study NCT ID: NCT06810895
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-02-06
First Post: 2024-10-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of AK104 (Cadonilimab) Combined with Chemotherapy for Recurrent or Metastatic Small Cell Neuroendocrine Carcinoma of the Cervix
Sponsor: Ding Ma
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module